BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35133575)

  • 21. Japanese POEMS syndrome with Thalidomide (J-POST) Trial: study protocol for a phase II/III multicentre, randomised, double-blind, placebo-controlled trial.
    Katayama K; Misawa S; Sato Y; Sobue G; Yabe I; Watanabe O; Nishizawa M; Kusunoki S; Kikuchi S; Nakashima I; Ikeda S; Kohara N; Kanda T; Kira J; Hanaoka H; Kuwabara S;
    BMJ Open; 2015 Jan; 5(1):e007330. PubMed ID: 25573527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lenalidomide-Induced Ischemic Cerebrovascular Disease in Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
    Mitsutake A; Matsumoto H; Hatano K; Irie K; Tsukada N; Hashida H
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):e102-e103. PubMed ID: 29395638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cereblon expression is a prognostic marker in newly diagnosed POEMS syndrome treated with lenalidomide plus dexamethasone.
    Cai QQ; Gao XM; Le J; Zhao H; Cai H; Cao XX; Li J
    Ann Hematol; 2021 Jun; 100(6):1547-1552. PubMed ID: 33839882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [POEMS syndrome treated with lenalidomide plus high-dose dexamethasone as a pre-transplant induction therapy].
    Matsuura S; Ogusa E; Taguchi J; Imai N; Fujita H; Tomita N; Ishigatsubo Y; Fujisawa S
    Rinsho Ketsueki; 2012 Dec; 53(12):2025-8. PubMed ID: 23318971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome.
    Li J; Huang XF; Cai QQ; Wang C; Cai H; Zhao H; Zhang L; Cao XX; Gale RP; Zhou DB
    Am J Hematol; 2018 Jun; 93(6):803-809. PubMed ID: 29603764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. POEMS syndrome: origination from clonal plasma cells or B cells?
    Zhou L; Lu J; Lin Z; Wang X; Luo L; Wang C; Hong L; Xu R; Huang H
    Hematology; 2023 Dec; 28(1):2186044. PubMed ID: 36897012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial.
    Durie BGM; Hoering A; Abidi MH; Rajkumar SV; Epstein J; Kahanic SP; Thakuri M; Reu F; Reynolds CM; Sexton R; Orlowski RZ; Barlogie B; Dispenzieri A
    Lancet; 2017 Feb; 389(10068):519-527. PubMed ID: 28017406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. POEMS syndrome, congestive heart failure and thalidomide -food for thought.
    Tageja N
    Intern Med; 2010; 49(17):1919; author reply 1921. PubMed ID: 20823658
    [No Abstract]   [Full Text] [Related]  

  • 29. Pachymeningeal involvement in POEMS syndrome: dramatic cerebral MRI improvement after lenalidomide therapy.
    Briani C; Manara R; Lessi F; Citton V; Zambello R; Adami F
    Am J Hematol; 2012 May; 87(5):539-41. PubMed ID: 22389216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lenalidomide in patients with POEMS syndrome: a systematic review and pooled analysis.
    Zagouri F; Kastritis E; Gavriatopoulou M; Sergentanis TN; Psaltopoulou T; Terpos E; Dimopoulos MA
    Leuk Lymphoma; 2014 Sep; 55(9):2018-23. PubMed ID: 24295131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Rapid improvement of fluid retention with lenalidomide plus low-dose dexamethasone for POEMS syndrome relapsed after autologous peripheral blood stem cell transplantation].
    Ohashi K; Yokoyama A; Kagoo T; Hosoda T; Yamamoto R; Yoneda M; Kudo M; Boku S; Ueno H; Yano T
    Rinsho Ketsueki; 2013 Jul; 54(7):670-4. PubMed ID: 23912352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical observation of thalidomide combined with VAD regimen for treatment of osteosclerotic myeloma (POEMS syndrome)].
    Zhou JW; Sun H; Gan SL; Liu YF; Sun L; Wan DM; Meng XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):348-51. PubMed ID: 22541096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the Efficacy of Thalidomide Plus Dexamethasone-Based Regimens in Patients With Relapsed/Refractory Multiple Myeloma Who Received Prior Chemotherapy, Including Bortezomib and Lenalidomide: KMM-166 Study.
    Jung KS; Kim K; Kim HJ; Kim SH; Lee JO; Kim JS; Lee JJ; Eom HS; Min CK; Shin HJ
    Clin Lymphoma Myeloma Leuk; 2020 Feb; 20(2):e97-e104. PubMed ID: 31831372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of POEMS syndrome associated with Waldenström's macroglobulinemia and treated with lenalidomide].
    Furuta N; Tashiro Y; Ikeda M; Fujita Y; Okamoto K
    Rinsho Shinkeigaku; 2012; 52(3):186-9. PubMed ID: 22453045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of POEMS syndrome with bortezomib and dexamethasone, combined with radiotherapy, and followed by autologous stem cell transplantation.
    Ishii Y; Yamazaki E; Ishiyama Y; Yamamoto E; Hattori Y; Hagihara M; Tomita N; Ishigatsubo Y
    Int J Hematol; 2013 Dec; 98(6):723-8. PubMed ID: 24166587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].
    Adam Z; Pour L; Krejčí M; Zahradová L; Szturz P; Koukalová R; Rehák Z; Nebeský T; Hájek R; Král Z; Mayer J
    Vnitr Lek; 2012 Nov; 58(11):856-66. PubMed ID: 23256832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocrine Evaluation in POEMS Syndrome: A Cohort Study.
    Yang H; Zhao H; Gao X; Huang X; Cao X; Zhou D; Xia W; Li J
    Front Endocrinol (Lausanne); 2020; 11():536241. PubMed ID: 33193075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.
    He T; Zhao A; Zhao H; Cai H; Feng J; Zhang L; Cao X; Zhou D; Li J
    Ann Hematol; 2019 Mar; 98(3):735-743. PubMed ID: 30612232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study.
    Misawa S; Sato Y; Katayama K; Hanaoka H; Sawai S; Beppu M; Nomura F; Shibuya K; Sekiguchi Y; Iwai Y; Watanabe K; Amino H; Ohwada C; Takeuchi M; Sakaida E; Nakaseko C; Kuwabara S
    BMJ Open; 2015 Nov; 5(11):e009157. PubMed ID: 26560063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [POEMS syndrome. An interdisciplinary clinical challenge].
    Braun SA; Albrecht P; Methner A; Hanneken S
    Hautarzt; 2011 Oct; 62(10):722-5. PubMed ID: 21915731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.